This opens the door to making mistakes—ones that could worsen your side effects, affect how much weight you’ll lose, or even ...

As GLP-1 pills for weight loss enter the U.S. market, some pharmaceutical companies are testing the possibility of a gene therapy to stimulate GLP-1 production, The Washington Post reported Jan. 24.

However, not everyone is willing—or able—to indefinitely commit to GLP-1s.

Sun Pharma has received approval from the Drugs Controller General of India to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 receptor ...

Higher-income households with at least one user of GLP-1 class of weight loss drugs cut their grocery spending by nearly 9%, a recent study based on data from the market research firm Numerator ...

Novo Nordisk A/S Q3 costs, Q4 savings, and oral Wegovy launch drive EPS upside. Click for this NVO stock update and earnings ...

As GLP-1 drugs become more available, some people might use them despite not having excess weight.